TD Asset Management’s Palvella Therapeutics PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.08M Sell
22,146
-600
-3% -$89K ﹤0.01% 879
2026
Q2
$3.48M Hold
22,746
– – ﹤0.01% 878
2026
Q1
$2.84M Buy
+22,746
New +$2.37M ﹤0.01% 894

Other funds holding PVLA

TD Asset Management's PVLA Position: Q3 2026 in Review

TD Asset Management reduced its Palvella Therapeutics (PVLA) stake by 2.6% in Q3 2026, selling an estimated $89K and leaving 22,146 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #879.

TD Asset Management first reported a position in PVLA in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.48M in Q2 2026. 199 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.

  • TD Asset Management held 22,146 shares of Palvella Therapeutics worth $3.08M as of Q3 2026.
  • TD Asset Management sold 600 Palvella Therapeutics shares in Q3 2026, an estimated $89K.
  • Palvella Therapeutics made up ﹤0.01% of TD Asset Management's portfolio in Q3 2026, its #879 holding.
  • TD Asset Management first reported a position in Palvella Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • TD Asset Management's Palvella Therapeutics position peaked at $3.48M in Q2 2026.
  • 199 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.

Based on TD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.